The Next Revolution in Blood Technology: Pathogen Reduction

The Next Revolution in Blood Technology: Pathogen Reduction

The blood industry has been shaken by a series of seismic shifts in recent years and the next shock is already cresting the horizon: Pathogen Reduction Technology (PRT) has the potential to transform how blood products reach patients. Other upsets have been sudden and jarring, such as 2016’s Zika epidemic and its nation-wide impact on blood availability.  In the span of a single year, an emerging pathogen was identified as a threat to the blood supply, nucleic acid tests were developed, and a new guidance was adopted by the FDA.

Read More

Blood & Circuits: RAND Corp. Report on the US Blood Supply

Blood & Circuits: RAND Corp. Report on the US Blood Supply

The health of the United States depends on blood and tech. Blood and blood products play a key and irreplaceable role in medicine: 5 million people per year receive transfusions of red blood cells, clotting factors or plasma products. Traditionally, the technological aspects of blood has long focused on improving the safety, collection, and storage of blood.

Read More